2014 Joint ACTRIMS-ECTRIMS Meeting

Featuring the following themes... -Diagnosis, phenotypes, and variants of MS and related disorders -Factors that determine MS susceptibility, disease course, and prognosis: The roles and interactions of genetics, epigenetics, the microbiome, environmental factors, pregnancy, age, comorbidities, and risk behaviors in determining MS susceptibility and disease course -Pathogenesis of MS relapses and progression: the link between inflammation and neurodegeneration -Mechanisms, detection, and significance of gray matter pathology in MS -Methods to monitor MS disease activity and severity: Patient self-report and automated self-assessment, new clinician-reported outcomes, standard and advanced imaging, and biomarkers -Current, emerging, and future disease therapies for relapsing-remitting and progressive MS and related disorders -Treatment strategies: Early treatment, switching therapies, treating-to-target of no evidence of disease activity, personalized treatment, and post-marketing monitoring of safety and efficacy